| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.61 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |